bad cholesterol Tag's Archives
The U.S. FDA reaffirmed its stance that high level of LDL or “bad cholesterol,” is key risk factor for heart diseases such as heart attack, stroke etc, and reduction in LDL cholesterol lowers the risk of these diseases.
The agency was reviewing of data from ENHANCE, a trial, which was comparing Zocor (HMG-CoA reductase inhibitor), a drug inhibit the production of cholesterol in the liver, in combination to Vytorin with Zetia (ezemtimibe), which limits the cholesterol absorption.
Preliminary results from ENHANCE had shown that there was no considerable difference in the thickness of the walls of the blood vessels of the neck. Though, the LDL cholesterol reduction, in patients with Vytorin compared to Zocor was significant.
bad cholesterol, f.d.a, heart attack, heart diseases, stroke
